C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CWBHF Equity

Charlotte's Web Holdings

OTCMKTS · CWBHF

$0.32
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
44/100 composite
Fundamentals50
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Charlotte’s Web Holdings earns a Neutral rating with a 44-point composite and low conviction at two out of five. Fundamentals provide the strongest pillar contribution at 50 points, supported primarily by a gross-margin subscore above 70 and a cash-runway subscore above 53. Regulatory follows closely at 49 points, where the absence of enforcement hits offsets weak filing cadence. Market contributes 40 points because institutional pricing feeds provide no current quote, limiting price-based confirmation. Editorial ranks last at 30 points, reflecting no recorded newsroom or brief activity in CIN newsroom coverage. The pillar mix supports neutrality rather than a directional stance, while the stretched financial condition caps conviction.

Licensed fundamentals data show year-over-year revenue contracting by roughly 9%, weakening the revenue-growth subscore to 41. Gross margin remains the clearest operating asset at approximately 42%, but that level has not translated into profitability. Operating margin stands near negative 39%, EBITDA remains negative at almost $14 million, and net loss exceeds $36 million. The cash-burn ratio is about 0.15, consistent with the stretched designation and insufficient to establish balance-sheet durability. Primary regulatory filings show no captured latest filing date, producing a cadence subscore of 25. No regulatory events appear across either the 90-day or 180-day windows, and no enforcement hits support the stronger 80-point enforcement subscore. Filing visibility, rather than enforcement pressure, remains the regulatory constraint.

The forward catalyst sits squarely within fundamentals, the highest-scoring pillar. Gross margin already provides a comparatively firm base, so improved revenue conversion could narrow the deeply negative operating margin and reduce EBITDA losses. A more consistent filing cadence would improve transparency, but it ranks behind commercial execution because the fundamental pillar carries the highest contribution and revenue contraction remains its central drag. Fresh licensed fundamentals data showing sales stabilization would strengthen the composite more directly than renewed editorial activity or market-price availability alone. The single most important signal to watch is a return to positive year-over-year revenue growth.

Scored: 2026-09-23Valid through: 2026-11-07Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
700 TECH COURT, LOUISVILLE, CO, 80027
Phone
1-720-617-7303
SEC CIK
1750155
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$89.8M
Enterprise value
$148.3M
Price to book
12.67
Price to sales
1.84
EV / EBITDA
-1.98
Revenue (TTM)
$48.8M
Gross profit (TTM)
$20.7M
EBITDA
$-13.7M
Operating margin
-38.8%
Profit margin
-75.1%
Rev growth YoY
-9.0%
Return on equity
-1217.1%
Return on assets
-13.5%
EPS (TTM)
$-0.23
EPS est. current year
$-0.15
Wall St. target price
$0.25
Shares outstanding
270.5M
Insider ownership
47.2%
Institutional ownership
1.3%
Beta
2.27
Full-time employees
112
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Charlotte's Web Holdings (CWBHF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Charlotte's Web Holdings (CWBHF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (1 bullish signal, 2 bearish signals.)

Bullish and bearish analyst opinions for Charlotte's Web Holdings (CWBHF)

Bullish view. Charlotte's Web is one of the best-known CBD brands in North America with strong DTC and mass-retail distribution; bulls model any FDA action on CBD as dietary supplement as a step-change catalyst for the whole category, with Charlotte's Web positioned as the brand-share leader.

Bearish view. Bears cite persistent CBD-category revenue declines, cash-flow pressure, and dependence on future FDA rulemaking that has been stalled for years without resolution.

Live ratings, price targets, and consensus figures for Charlotte's Web Holdings appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CWBHF are maintained by Cannabis Investor News and refreshed throughout the trading day.